Talquetamab with Iberdomide
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Dose Escalation: Dose Level (DL) 1
Not yet accepting
Experimental:Dose Escalation: DL 2
Not yet accepting
Experimental:Dose Escalation: DL 3
Not yet accepting
Experimental:Dose Expansion
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.